Active pharmaceutical ingredients that require special handling due to toxicity and use extremely small doses in finished drugs. HPAPIs are prominent in oncology research.
Glossary
High Potency API (HPAPI)
02.27.12
Related Contract Manufacturing:
-
APIs | Breaking News | Facilities | Industry News
Curia to Expand U.S. Commercial Manufacturing Capability
Roughly $35 million will be invested to expand manufacturing and product-handling solutions for complex small molecules.
-
Bio News | Breaking News | cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Facilities | Industry News | Solid Dosage/Creams/Ointments
Enteris BioPharma Completes Expansion of Manufacturing Facility
Also launches CDMO business for the development and manufacture of difficult to formulate drugs and highly potent compounds.Tim Wright, Editor, Contract Pharma
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
Tubulis, WuXi Biologics and WuXi STA Form Strategic Pact
Will advance a new generation of antibody-drug conjugates towards clinical evaluation.Contract Pharma Staff
-
Drug Development
Solving the Pharma Talent Crunch
Addressing talent shortages in today's pharmaceutical sectorJim Sykes, Managing Director, Pharmaceutical & Life Sciences, Alexander Mann Solutions
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
